JACOB TEBBS: Open Payments
NPI 1154870251 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 36 payments from 9 companies in 2025. Trend: 2023 $254 · 2024 $905 · 2025 $776
Food & beverage: $623Education: $153
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $222 |
| ABBVIE INC. | 11 | $206 |
| Novartis Pharmaceuticals Corporation | 7 | $144 |
| Organon LLC | 3 | $68 |
| Lilly USA, LLC | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $27 |
| LEO Pharma Inc. | 1 | $24 |
| UCB, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $18 |
Products named: TREMFYA, SKYRIZI, COSENTYX, VTAMA, RINVOQ, EBGLYSS, Sotyktu, ANZUPGO.
Industry payments across ID — which companies pay providers there.
